| Tournament | Round | Opponent | Judge | Cites | Round Report | Open Source | Edit/Delete |
|---|---|---|---|---|---|---|---|
| Jack Howe | 2 | Christopher Columbus AM | Anish Ramireddy |
|
|
| |
| Kentucky | 4 | Durham JH | Trey Roark |
|
|
| |
| Kentucky | 5 | Westwood WY | Ritenour, Amelia |
|
|
| |
| Kentucky | 1 | Woodrow Wilson CO | Ki Radcliffe |
|
|
|
| Tournament | Round | Report |
|---|---|---|
| Jack Howe | 2 | Opponent: Christopher Columbus AM | Judge: Anish Ramireddy 1AC - Rawls |
| Kentucky | 4 | Opponent: Durham JH | Judge: Trey Roark 1AC - Cap |
| Kentucky | 5 | Opponent: Westwood WY | Judge: Ritenour, Amelia 1AC - Stock |
| Kentucky | 1 | Opponent: Woodrow Wilson CO | Judge: Ki Radcliffe 1AC - Innovation Access |
To modify or delete round reports, edit the associated round.
Cites
| Entry | Date |
|---|---|
SO - 3 of 4 CPTournament: Jack Howe | Round: 2 | Opponent: Christopher Columbus AM | Judge: Anish Ramireddy Counterplan: At least three-quarters of WTO member nations, excluding the United States, should extend Medical IP TRIP waivers, to all 36 member nations on the UN's recognized list of Lesser developed countries.Entirely solves while avoiding politicsSiripurapu 21 Anshu Siripurapu covers economics, energy, and geopolitics, BA in political economy from the University of Southern California. "The Debate Over a Patent Waiver for COVID-19 Vaccines: What to Know." Council on Foreign Relations, May 26, 2021, www.cfr.org/in-brief/debate-over-patent-waiver-covid-19-vaccines-what-know. | 9/18/21 |
SO - Infrastructure CP V2Tournament: Kentucky | Round: 1 | Opponent: Woodrow Wilson CO | Judge: Ki Radcliffe ====Disease specific funding causes budget imbalances and inequity in treatment. Using that funding to improve primary health care is key to non-HIV diseases and pandemics.==== | 9/18/21 |
SO - Innovation DA V1Tournament: Kentucky | Round: 1 | Opponent: Woodrow Wilson CO | Judge: Ki Radcliffe Innovation DAPharmaceutical innovation is accelerating now – new medicines are substantially better than existing treatments.Wills and Lipkus, PhD, 20 – Todd J. Wills ~Managing Director @ Chemical Abstracts Service, MBA from THE Ohio State University~ and Alan H. Lipkus ~Senior Data Analyst @ Chemical Abstracts Service, PhD Physical Chemistry from the University of Rochester~, "Structural Approach to Assessing the Innovativeness of New Drugs Finds Accelerating Rate of Innovation," ACS Medicinal Chemistry Letters, Vol. 11, 2020, https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00319 C.VC The biopharmaceutical industry is uniquely reliant on IP protections – undermining them would kill innovation by making an already expensive process completely unfeasible.Kristina M. Lybecker, PhD, 17 ~PhD Economics, Associate Professor of Economics @ Colorado College~, "Intellectual Property Rights Protection and the Biopharmaceutical Industry: How Canada Measures Up," Fraser Institute, January 2017, https://www.fraserinstitute.org/sites/default/files/intellectual-property-rights-protection-and-the20biopharmaceutical-industry.pdf C.VC Pharmaceutical innovation is key to protecting against future pandemics, bioterrorism, and antibiotic resistance.Marjanovic and Fejiao '20 Marjanovic, Sonja, and Carolina Feijao. Sonja Marjanovic, Ph.D., Judge Business School, University of Cambridge. Carolina Feijao, Ph.D. in biochemistry, University of Cambridge; M.Sc. in quantitive biology, Imperial College London; B.Sc. in biology, University of Lisbon. "Pharmaceutical Innovation for Infectious Disease Management: From Troubleshooting to Sustainable Models of Engagement." (2020). ~Quality Control~ Bioterrorism and future pandemics cause extinction.Hamish De Bretton-Gordon, CBRN Expert @ British Army, 20 ~Director @ DBG Defense, Consultant on CBRN and Biosecurity~, "Biosecurity in the Wake of COVID-19: The Urgent Action Needed," Combatting Terrorism Center Sentinel, November/December 2020, Volume 13, Issue 11, https://ctc.usma.edu/biosecurity-in-the-wake-of-covid-19-the-urgent-action-needed/ C.VC | 9/18/21 |
SO - Innovation DA V2Tournament: Jack Howe | Round: 2 | Opponent: Christopher Columbus AM | Judge: Anish Ramireddy Pharmaceutical innovation is accelerating now – new medicines are substantially better than existing treatments.Wills and Lipkus, PhD, 20 – Todd J. Wills ~Managing Director @ Chemical Abstracts Service, MBA from THE Ohio State University~ and Alan H. Lipkus ~Senior Data Analyst @ Chemical Abstracts Service, PhD Physical Chemistry from the University of Rochester~, "Structural Approach to Assessing the Innovativeness of New Drugs Finds Accelerating Rate of Innovation," ACS Medicinal Chemistry Letters, Vol. 11, 2020, https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00319 C.VC The biopharmaceutical industry is uniquely reliant on IP protections – undermining them would kill innovation by making an already expensive process completely unfeasible.Kristina M. Lybecker, PhD, 17 ~PhD Economics, Associate Professor of Economics @ Colorado College~, "Intellectual Property Rights Protection and the Biopharmaceutical Industry: How Canada Measures Up," Fraser Institute, January 2017, https://www.fraserinstitute.org/sites/default/files/intellectual-property-rights-protection-and-the20biopharmaceutical-industry.pdf C.VC Pharmaceutical innovation is key to protecting against future pandemics, bioterrorism, and antibiotic resistance.Marjanovic and Fejiao '20 Marjanovic, Sonja, and Carolina Feijao. Sonja Marjanovic, Ph.D., Judge Business School, University of Cambridge. Carolina Feijao, Ph.D. in biochemistry, University of Cambridge; M.Sc. in quantitive biology, Imperial College London; B.Sc. in biology, University of Lisbon. "Pharmaceutical Innovation for Infectious Disease Management: From Troubleshooting to Sustainable Models of Engagement." (2020). ~Quality Control~ Bioterrorism and future pandemics cause extinction.Hamish De Bretton-Gordon, CBRN Expert @ British Army, 20 ~Director @ DBG Defense, Consultant on CBRN and Biosecurity~, "Biosecurity in the Wake of COVID-19: The Urgent Action Needed," Combatting Terrorism Center Sentinel, November/December 2020, Volume 13, Issue 11, https://ctc.usma.edu/biosecurity-in-the-wake-of-covid-19-the-urgent-action-needed/ C.VC | 9/18/21 |
SO - Politix DA V1Tournament: Jack Howe | Round: 2 | Opponent: Christopher Columbus AM | Judge: Anish Ramireddy Drug price reform coming now – fight is ramping up but Biden has the opportunityCancryn 9/9 Cancryn, Adam. Adam Cancryn is a health care reporter for POLITICO Pro, graduate of Washington and Lee University."Biden admin backs direct government drug price negotiations." POLITICO, 9 Sept. 2021, www.politico.com/news/2021/09/09/biden-drug-price-negotiations-510828. Biden's PC is key to wrangle democrats and counter pharma lobbyingJohnson 8/12 Johnson, Jake, writer for Alternet . "Joe Biden throws support behind bold reforms to slash drug prices." Alternet, August 12, 2021, www.alternet.org/2021/08/biden-medicare-negotiate-prices. WTO waiver takes time, energy, and political capital away from domestic legislation – big pharma and EU alliesBhadrakumar 5/9 M K Bhadrakumar is a former Indian diplomat. "Biden's talk of vaccine IP waiver is political theater." Asia Times, May 9, 2021, asiatimes.com/2021/05/bidens-talk-of-vaccine-ip-waiver-is-political-theater. Drug price controls massively reduce healthcare costs across the board – even assuming conservative modelsGamba 6/9 Gamba, Tyler. Author at the AJMC. "Adoption of the Lower Drug Costs Now Act May Lead to Billions in Savings." AJMC, 9 June 2021, www.ajmc.com/view/adoption-of-the-lower-drug-costs-now-act-may-lead-to-billions-in-savings. Collapses the economyHowrigon, 16 — Ron Howrigon, M.S. in Economics with a focus on Health Economics from North Carolina State University, President and Founder of Fulcrum Strategies, 18 Years of Experience in Healthcare, 12-30-2016, "Flatlining: How Healthcare Could Kill the U.S. Economy," Greenbranch Publishing, 1st Edition, Accessed via Minnesota Libraries, Date Accessed: 8-10 Economic decline causes nuclear warTønnesson, 15 — Stein Tønnesson, Leader of East Asia Peace program at Uppsala University, Research Professor at the Peace Research Institute Oslo, "Deterrence, Interdependence and Sino–US Peace" International Area Studies Review, Review Essay, Volume 18, Issue 3, Pages 297-311, SAGE Journals, Minnesota Libraries, Date Accessed: 8-4 | 9/18/21 |
Open Source
| Filename | Date | Uploaded By | Delete |
|---|---|---|---|
9/18/21 | gordysun21@gmailcom |
| |
9/12/21 | gordysun21@gmailcom |
| |
9/18/21 | gordysun21@gmailcom |
| |
9/18/21 | gordysun21@gmailcom |
|